Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-27 2022-06-03 161442
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-OXYCODONE CR 5.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-09-23 165332
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-01-26 177612
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2022-12-16 177672
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447

Showing 2921 to 2940 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-01-03 2019-01-03 71112
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436

Showing 301 to 320 of 356